homeWelcome, sign in or click here to subscribe.login
     


 

 

Business


print  email to a friend  reprints add to mydjc  

June 16, 2020

NodThera

Biotechnology company NodThera closed a $55 million round of Series B financing led by Novo Ventures and new investors Cowen Healthcare Investments and Sanofi Ventures. The round was also financed by existing investors 5AM Ventures, F-Prime Capital, Sofinnova Partners and Epidarex Capital. NodThera is using the money to advance its pipeline of drugs to treat diseases driven by chronic inflammation. The company is based in the United Kingdom and has an office in Seattle.




Email or user name:
Password:
 
Forgot password? Click here.